.
MergerLinks Header Logo

Announced

Completed

Merck completed the acquisition of Imago BioSciences for $1.35bn.

Financials

Edit Data
Transaction Value£1,135m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Domestic

biopharmaceuticals

Public

Majority

Acquisition

United States

Single Bidder

Pharmaceuticals

Friendly

Tender Offer

Completed

Synopsis

Edit

Merck, a science and technology company, completed the acquisition of Imago BioSciences, a clinical-stage biopharmaceutical company, for $1.35bn. “We continue to invest in our pipeline with a focus on applying our unique capabilities to unlock the value of breakthrough science for the patients we serve. This acquisition of Imago augments our pipeline and strengthens our presence in the growing field of hematology," Robert M. Davis, Merck President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US